Tag: carcinoid syndrome

Lexicon Pharmaceuticals, Inc. Clinical Trial Recruiting Carcinoid Syndrome Patients

Patients with carcinoid syndrome, whose symptoms are not managed by octreotide therapy, are being recruited for a Phase 2 clinical trial of Lexicon Pharmaceuticals’ LX1606 (a.k.a. LX1032).  The trial has been given Fast Track status in the U.S. and …

READ MORE

Carcinoid Syndrome Clinical Trial to Be Featured on Webcast

Lexicon Pharmaceuticals’ clinical trial LX1032 for carcinoid syndrome will be among the clinical programs that are reviewed in-depth on April 8, 2010 when the company holds its Annual R&D Day from 7:30 to 11:00 am, Eastern Time, in New York City. …

READ MORE

Sandostatin Mobile Administration Program for Carcinoid Syndrome Patients

If you are a carcinoid patient who needs Sandostatin® LAR Depot injections, you may be eligible for the Mobile Administration Program.  This program helps alleviate the stress of driving to a doctor’s office (or finding one where you live or while on vacation),…

READ MORE

Carcinoid Heart Disease: Facts You Need to Know

“Serotonin seems to be the single most damaging substance in carcinoid heart disease,” explains JEROME S. ZACKS, MD.  Dr. Zacks, a cardiologist, is a member of the Carcinoid/ Neuroendocrine Tumor Center at Mount Sinai School of Medicine in New York City,… READ MORE

New CEO Named at Carcinoid Cancer Foundation

Keith R.P. Warner, President of Highland Water LLC in Denver, Colorado, has been named Chief Executive Officer of the Carcinoid Cancer Foundation (CCF). The appointment was announced by Richard R.P. Warner, M.D., Medical Director of the Foundation,…

READ MORE

How Do I Find a Carcinoid/NET Doctor?

“How can I find a doctor who knows how to diagnose or treat carcinoid?” is one of the most frequent questions we hear from callers to our information/support line.  And we can help you.  There are carcinoid/neuroendocrine tumor (NET) specialists…

READ MORE